GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » Capex-to-Revenue

MGX (Metagenomi) Capex-to-Revenue : 0.03 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Metagenomi Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Metagenomi's Capital Expenditure for the three months ended in Jun. 2024 was $-0.67 Mil. Its Revenue for the three months ended in Jun. 2024 was $20.01 Mil.

Hence, Metagenomi's Capex-to-Revenue for the three months ended in Jun. 2024 was 0.03.


Metagenomi Capex-to-Revenue Historical Data

The historical data trend for Metagenomi's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metagenomi Capex-to-Revenue Chart

Metagenomi Annual Data
Trend Dec21 Dec22 Dec23
Capex-to-Revenue
11.95 0.81 0.22

Metagenomi Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.18 0.14 0.08 0.03

Competitive Comparison of Metagenomi's Capex-to-Revenue

For the Biotechnology subindustry, Metagenomi's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metagenomi's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Metagenomi's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Metagenomi's Capex-to-Revenue falls into.



Metagenomi Capex-to-Revenue Calculation

Metagenomi's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-9.814) / 44.756
=0.22

Metagenomi's Capex-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.665) / 20.008
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Metagenomi  (NAS:MGX) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Metagenomi Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Metagenomi's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Metagenomi Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website

Metagenomi Headlines